Clinical Trials Browser

Inflammatory Breast Neoplasms × pegfilgrastim × Clear all

NCT00066443 2023-08-04

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00346229 2016-03-22

Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

Phase 1 Terminated

Breast Neoplasms, Inflammatory Breast Neoplasms